Common Stock, Shares, Outstanding of Matinas BioPharma Holdings, Inc. from 31 Dec 2013 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Matinas BioPharma Holdings, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2013 to 30 Sep 2025.
  • Matinas BioPharma Holdings, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 5,901,091, a 16% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Matinas BioPharma Holdings, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 5,901,091 +814,106 +16% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 5,086,985 -245,729,179 -98% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 5,086,985 -212,395,845 -98% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 5,086,985 +741,694 +17% 31 Dec 2024 10-Q 10 Nov 2025 2025 Q3
Q3 2024 5,086,985 -212,177,541 -98% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 250,816,164 +33,551,638 +15% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 217,482,830 +218,304 +0.1% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 4,345,291 -212,919,235 -98% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q3 2023 217,264,526 +400,000 +0.18% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 217,264,526 +400,000 +0.18% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 217,264,526 +400,000 +0.18% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 217,264,526 +995,076 +0.46% 31 Dec 2022 10-K 27 Mar 2024 2023 FY
Q3 2022 216,864,526 +616,998 +0.28% 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 216,864,526 +2,237,004 +1% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 216,864,526 +12,580,554 +6.2% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 216,269,450 +16,156,019 +8.1% 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 216,247,528 +17,277,770 +8.7% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 214,627,522 +15,754,045 +7.9% 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 204,283,972 +7,081,034 +3.6% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 200,113,431 +36,956,447 +23% 31 Dec 2020 10-K/A 11 Mar 2022 2021 FY
Q3 2020 198,969,758 +36,249,484 +22% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 198,873,477 +54,667,627 +38% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 197,202,938 +54,211,496 +38% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 163,156,984 +49,869,314 +44% 31 Dec 2019 10-K 29 Mar 2021 2020 FY
Q3 2019 162,720,274 +65,023,031 +67% 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 144,205,850 +49,968,932 +53% 30 Jun 2019 10-Q 13 Aug 2019 2019 Q2
Q1 2019 142,991,442 +49,009,880 +52% 31 Mar 2019 10-Q 13 May 2019 2019 Q1
Q4 2018 113,287,670 +19,916,541 +21% 31 Dec 2018 10-K 09 Mar 2020 2019 FY
Q3 2018 97,697,243 +4,747,147 +5.1% 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 94,236,918 +2,264,595 +2.5% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 93,981,562 +2,996,370 +3.3% 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 93,371,129 +35,211,634 +61% 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q3 2017 92,950,096 +35,030,387 +60% 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 91,972,323 +34,378,909 +60% 30 Jun 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 90,985,192 +33,391,778 +58% 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 58,159,495 +979,347 +1.7% 31 Dec 2016 10-K 16 Mar 2018 2017 FY
Q3 2016 57,919,709 +712,374 +1.2% 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 57,593,414 +625,724 +1.1% 30 Jun 2016 10-Q 15 Aug 2016 2016 Q2
Q1 2016 57,593,414 +10,817,744 +23% 31 Mar 2016 10-Q 13 May 2016 2016 Q1
Q4 2015 57,180,148 +24,887,498 +77% 31 Dec 2015 10-K 31 Mar 2017 2016 FY
Q3 2015 57,207,335 +25,039,685 +78% 30 Sep 2015 10-Q 10 Nov 2015 2015 Q3
Q2 2015 56,967,690 +24,967,690 +78% 30 Jun 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 46,775,670 +14,775,670 +46% 31 Mar 2015 10-Q 15 May 2015 2015 Q1
Q4 2014 32,292,650 +292,650 +0.92% 31 Dec 2014 10-K 30 Mar 2016 2015 FY
Q3 2014 32,167,650 30 Sep 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 32,000,000 30 Jun 2014 10-Q 08 Aug 2014 2014 Q2
Q1 2014 32,000,000 31 Mar 2014 10-Q 06 Jun 2014 2014 Q1
Q4 2013 32,000,000 31 Dec 2013 10-K 31 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.